abstract |
The invention relates to the field of medicine, pharmacology and concerns in particular a new pharmaceutical combination as well as a new drug group with anxiolytic action including phenazepam, vitamin B6 and magnesium in effective amounts. The aim of the invention is to provide a complex, highly effective, anxiolytically effective preparation with minimal side effects that is suitable for treating a wide range of anxiety disorders. The technical result is a synergistic enhancement of the anxiolytic effect of phenazepam in combination with magnesium and vitamin B6 while reducing the side effects of phenazepam in said combination. |